Organ-on-Chip Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL ORGAN-ON-CHIP INDUSTRY

2.1 Summary about Organ-on-Chip Industry

2.2 Organ-on-Chip Market Trends

2.2.1 Organ-on-Chip Production & Consumption Trends

2.2.2 Organ-on-Chip Demand Structure Trends

2.3 Organ-on-Chip Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Lung-on-Chip

4.2.2 Heart-on-Chip

4.2.3 Liver-on-Chip

4.2.4 Intestine-on-Chip

4.2.5 Kidney-on-Chip

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Pharmaceuticals

4.3.2 Research Organizations

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Lung-on-Chip

5.2.2 Heart-on-Chip

5.2.3 Liver-on-Chip

5.2.4 Intestine-on-Chip

5.2.5 Kidney-on-Chip

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Pharmaceuticals

5.3.2 Research Organizations

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Lung-on-Chip

6.2.2 Heart-on-Chip

6.2.3 Liver-on-Chip

6.2.4 Intestine-on-Chip

6.2.5 Kidney-on-Chip

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Pharmaceuticals

6.3.2 Research Organizations

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Lung-on-Chip

7.2.2 Heart-on-Chip

7.2.3 Liver-on-Chip

7.2.4 Intestine-on-Chip

7.2.5 Kidney-on-Chip

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Pharmaceuticals

7.3.2 Research Organizations

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Lung-on-Chip

8.2.2 Heart-on-Chip

8.2.3 Liver-on-Chip

8.2.4 Intestine-on-Chip

8.2.5 Kidney-on-Chip

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Pharmaceuticals

8.3.2 Research Organizations

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Lung-on-Chip

9.2.2 Heart-on-Chip

9.2.3 Liver-on-Chip

9.2.4 Intestine-on-Chip

9.2.5 Kidney-on-Chip

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Pharmaceuticals

9.3.2 Research Organizations

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 CN Bio Innovations

10.1.2 Emulate

10.1.3 TissUse

10.1.4 Mimetas

10.1.5 HμREL® Corporation

10.1.6 Nortis

10.1.7 Insphero

10.1.8 Tara Biosystems

10.1.9 AxoSim Techologies LLC

10.2 Organ-on-Chip Sales Date of Major Players (2017-2020e)

10.2.1 CN Bio Innovations

10.2.2 Emulate

10.2.3 TissUse

10.2.4 Mimetas

10.2.5 HμREL® Corporation

10.2.6 Nortis

10.2.7 Insphero

10.2.8 Tara Biosystems

10.2.9 AxoSim Techologies LLC

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Organ-on-Chip Product Type Overview

Table Organ-on-Chip Product Type Market Share List

Table Organ-on-Chip Product Type of Major Players

Table Brief Introduction of CN Bio Innovations

Table Brief Introduction of Emulate

Table Brief Introduction of TissUse

Table Brief Introduction of Mimetas

Table Brief Introduction of HμREL® Corporation

Table Brief Introduction of Nortis

Table Brief Introduction of Insphero

Table Brief Introduction of Tara Biosystems

Table Brief Introduction of AxoSim Techologies LLC

Table Products & Services of CN Bio Innovations

Table Products & Services of Emulate

Table Products & Services of TissUse

Table Products & Services of Mimetas

Table Products & Services of HμREL® Corporation

Table Products & Services of Nortis

Table Products & Services of Insphero

Table Products & Services of Tara Biosystems

Table Products & Services of AxoSim Techologies LLC

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Organ-on-Chip Market Forecast (Million USD) by Region 2021f-2026f

Table Global Organ-on-Chip Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Organ-on-Chip Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Organ-on-Chip Market Forecast (Million USD) Share by Demand 2021f-2026f